Table 1 Baseline
SR Group, n = 85 | FB Group, n = 86 | Р value | |
|---|---|---|---|
FED, n (%) | 65 (76.5) | 56 (65.1) | 0.103 |
Forme fruste, n (%) | 12 (14.1) | 18 (20.9) | 0.241 |
Barlow, n (%) | 8 (9.4) | 12 (14.0) | 0.355 |
Male, n (%) | 59 (69.4) | 58 (67.4) | 0.782 |
Age, years | 57 (23–75) | 54 (19–74) | 0.092 |
Height, cm | 173 (148–192) | 175 (151;193) | 0.079 |
Weight, kg | 79.1 ± 14.6 | 77.1 ± 16.4 | 0.388 |
BMI, kg/m2 | 26.9 ± 4.3 | 25.4 ± 4.6 | 0.522 |
BSA, m2 | 1.94 ± 0.21 | 1.93 ± 0.24 | 0.801 |
NYHA I, n (%) | 7 (8.2) | 12 (14.0) | 0.234 |
NYHA II, n (%) | 22 (25.9) | 29 (33.7) | 0.263 |
NYHA III, n (%) | 54 (63.5) | 43 (50.0) | 0.742 |
NYHA IV, n (%) | 2 (2.4) | 2 (2.3) | 0.991 |
AF, n (%) | 22 (25.9) | 16 (18.6) | 0.252 |
Paroxysmal, n (%) | 2 (2.4) | 2 (2.3) | 0.991 |
Persistent, n (%) | 5 (5.9) | 3 (3.5) | 0.459 |
Long-standing, n (%) | 11 (12.9) | 9 (10.5) | 0.614 |
Permanent, n (%) | 4 (4.7) | 2 (2.3) | 0.398 |
CAD, n (%) | 10 (11.8) | 4 (4.7) | 0.090 |
Arterial hypertension, n (%) | 46 (54.1) | 42 (48.8) | 0.490 |
Diabetes mellitus, n (%) | 4 (4.7) | 5 (5.8) | 0.746 |
Moderate renal impairment, n (%) | 1 (1.2) | 1 (1.2) | 0.993 |
Peripheral vascular disease, n (%) | 5 (5.9) | 3 (3.5) | 0.459 |
Cerebrovascular disease, n (%) | 5 (5.9) | 4 (4.7) | 0.719 |
LV EF, % | 65.5 (49–80) | 67.0 (51–89) | 0.212 |
PA pressure, mm Hg | 48.5 (29–80) | 45.0 (29–94) | 0.053 |